Healio (12/14, Weldon) reports, “More than 60% of 12th graders who responded to a yearly survey of junior high and high school students reported not using alcohol, cannabis or nicotine in the past 30 days – the highest level of abstention in the survey’s history.” Notably, “rates of lifetime abstention … significantly increased in 2023 among 10th and 12th graders and were at or near the highest levels ever recorded by Monitoring the Future, a survey conducted yearly by the University of Michigan and funded by the National Institute on Drug Abuse.”

Related Links:

— “Survey: More US teens abstaining from drugs, alcohol,” Rose Weldon, Healio, December 14, 2023

Infectious Disease Advisor (12/14, Barowski, RN) reports, “Although HIV infection is associated with increased risk for mental” illnesses, “antiretroviral therapy mitigates this risk,” according to a study. The findings were published in Open Forum Infectious Diseases.

Related Links:

— “Antiretroviral Therapy Reduces Risk for Mental Health Disorders in HIV,” Janelle Barowski, Infectious Disease Advisor, December 14, 2023

Psychiatric News (12/14) reports, “Women who experience suicidal thoughts and behaviors may experience worsening symptoms in the days before and during menses, though the symptom changes vary significantly among individuals, according to a study.” The study found “suicidal planning was more likely to occur during the perimenstrual period compared with other phases of the menstrual cycle.” The findings were published in The American Journal of Psychiatry.

Related Links:

— “Suicidal Symptoms May Worsen for Some Women Before, During Menses,” APA Psychiatric News Alert, December 14, 2023

CNN (12/14, Howard) reports, “The first oral pill approved in the United States to treat postpartum depression is now available by prescription, according to the drugmakers.” The therapy, called Zurzuvae (zuranolone), which was approved by the FDA in August and “is now at specialty pharmacies, can also be shipped directly to patients, Biogen and Sage Therapeutics Inc. said in an announcement Thursday.” Notably, “the medication will cost $15,900 per course before insurance, raising some concerns about how many people will be able to access it.”

Related Links:

— “First postpartum depression pill now available in the US, drugmakers say,” Jacqueline Howard, CNN, December 14, 2023

Healio (12/13, Schaffer) reports, “CDC data show a spike in infective endocarditis deaths among young adults despite an overall decline in such deaths from 1999 to 2020, with researchers citing the role of comorbid opioid use disorder.” The findings were published in the Journal of the American Heart Association.

HealthDay (12/13, Mundell) also reports on the research.

Related Links:

— “,” Regina Schaffer, Healio, December 13, 2023